GenSpera Inc. – “Why Partner: The Partnering Process – Part Two”

NEW YORK, NY / ACCESSWIRE / July 30, 2015 / GenSpera Inc. (OTCQB: GNSZ) today published a new blog post on The Chairman’s Blog, written by the Company’s chief executive officer, Craig Dionne, Ph.D. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

In the 2nd post of his two-part blog, Dr. Dionne discusses the process of partnering, delving into the due diligence and timing involved in the identification of potential partners. “GenSpera has been actively engaged in this partnering process for over two years since the beginning of Phase II clinical trials in liver cancer. We started early because we knew that comfort in the validity of our science and clinical data would be generated as potential partners could see data develop and become familiar with our management team,” said Dr. Dionne. Read the full blog post from Dr. Dionne on TheChairmansBlog.com (http://www.thechairmansblog.com/genspera/craig-dionne/why-partner-part-two/).

About GenSpera

GenSpera Inc. is a San Antonio-based biotech company that unlocks conventional thinking to conceive, design, and develop cancer therapies. GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates within tumors. GenSpera’s lead drug candidate, mipsagargin, was granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in 2013 for evaluation in patients with hepatocellular carcinoma (liver cancer).

For additional information on GenSpera, visit www.genspera.com and connect on Twitter, LinkedIn, Facebook, YouTube and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 430931